Glenmark Generics (Europe) Limited (GGEL) is the European subsidiary of Glenmark Generics Ltd., engaged in marketing, licensing and distribution of generic products throughout Europe.
The generic formulations and API business in Europe has a robust product portfolio developed by a Europe-dedicated R&D team and has excellent supply chain resources
Glenmark Generics (Europe) Ltd headquartered in the UK operates through its own sales infrastructure in the UK and through licensing & distribution arrangements in other European markets.
The UK office based in Hatfield, Hertfordshire possesses the infrastructure to support licensing, regulatory submissions, project management, distribution of sales in the UK and across Europe.
Glenmark is building its presence in markets across Europe and seeks out opportunities to develop strategic alliances and marketing collaborations with leading generic companies operating in the EU markets.
Glenmark was awarded the prestigious SCRIP award in 2011 'Best Company in an Emerging Market' and 'Best Overall Pipeline' and also during 2008 for the Best Pharma company in the world - SME & the Best Company in Emerging Markets
- Core Sales Territory:
All of Europe
- Formed: 1977
- Number of employees: 8000